Hosted on MSN
Repligen appoints Martin Madaus as new board chair
Repligen ( (RGEN)) has provided an update. On January 6, 2026, Repligen Corporation announced that its board has elected independent director Dr. Martin D. Madaus as Chair of the Board, effective ...
WALTHAM, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that the Board has elected ...
(RTTNews) - Repligen Corp. (RGEN), a life sciences company, on Tuesday announced that its board has elected Martin Madaus as chair of the board, effective March 13, following the retirement of Tony ...
The "Bioprocess Filtration: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for bioprocess filtration is estimated to grow from $8.4 billion in 2025 to ...
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results